How can we explain the sudden 25% drop in surgical volume using Medtronic's Mazor X Stealth robotic-assisted surgery platform compared to last quarter?

Introduction

A sudden 25% drop in surgical volume using Medtronic's Mazor X Stealth robotic-assisted surgery platform is a significant concern that requires immediate attention and thorough analysis. To address this issue, I'll employ a systematic approach to identify, validate, and resolve the root cause while considering both short-term and long-term implications for our product and business.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be a seasonal component. Has this drop coincided with any particular time of year or holiday period?

Why it matters: Seasonal patterns could explain temporary fluctuations. Expected answer: No significant seasonal correlation. Impact on approach: If seasonal, we'd focus on anticipating and managing cyclical demand.

• Considering user segments, I'm wondering if this decline is uniform across all hospital types. Have we seen any differences in usage between large academic medical centers and smaller community hospitals?

Why it matters: Different user segments may have distinct issues or adoption barriers. Expected answer: The decline is relatively uniform across hospital types. Impact on approach: If segmented, we'd tailor our solutions to specific user groups.

• Thinking about recent changes, have there been any software updates or new feature releases for the Mazor X Stealth platform in the last quarter?

Why it matters: Recent changes could introduce bugs or usability issues. Expected answer: A minor software update was released two months ago. Impact on approach: If update-related, we'd focus on identifying and resolving specific issues introduced.

• Considering market dynamics, has there been any significant movement from competitors or changes in insurance reimbursement policies for robotic-assisted surgeries?

Why it matters: External factors could be influencing surgeon or hospital decisions. Expected answer: No major competitive or reimbursement changes noted. Impact on approach: If external factors are at play, we'd need to reassess our market positioning and value proposition.